CXCL10 and neoplasm: We also observed increased amounts of the CXCL10 chemokine (even if with high variability among experiments; p-value not significant; Figure 5B), able to recruit immune effectors as T lymphocytes, NK cells, and dendritic cells in the tumor microenvironment, in MDA-MB453 and MCF7 models after three doses of RT.